Killer treg cells ameliorate inflammatory insulitis in non-obese diabetic mice through local and systemic immunomodulation

International Immunology

Volumn 25, Issue 8, 2013, Pages 485-494

  Kaminitz, Ayelet ^a   Yolcu, Esma S ^b   Mizrahi, Keren ^a   Shirwan, Haval ^b   Askenasy, Nadir ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b University of Louisville School of Medicine   (United States)

Author keywords

Destructive insulitis; Fas ligand; Killer treg; New onset diabetes; NOD mice; Regulatory T cell

Indexed keywords

CD4 ANTIGEN; FAS LIGAND; GLUCOSE; INSULIN; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG MECHANISM; FEMALE; GLUCOSE BLOOD LEVEL; IMMUNOMODULATION; INSULIN BLOOD LEVEL; INSULITIS; LYMPH NODE; LYMPHOID ORGAN; NONHUMAN; NONOBESE DIABETIC MOUSE; OUTCOME ASSESSMENT; PANCREAS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; THYMUS;

DESTRUCTIVE INSULITIS; FAS-LIGAND; KILLER TREG; NEW-ONSET DIABETES; NOD MICE; REGULATORY T CELL;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; IMMUNOMODULATION; INFLAMMATION; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; MICE, SCID; T-LYMPHOCYTES, REGULATORY;

EID: 84880590239     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxt016     Document Type: Article

References (49)

1. Chatenoud, L. and Bach, J. F. 2005. Regulatory T cells in the control of autoimmune diabetes: the case of the NOD mouse. Int. Rev. Immunol. 24:247.
2. Jaeckel, E., Mpofu, N., Saal, N. and Manns, M. P. 2008. Role of regulatory T cells for the treatment of type 1 diabetes mellitus. Horm. Metab. Res. 40:126.
3. Sgouroudis, E. and Piccirillo, C. A. 2009. Control of type 1 diabetes by CD4+Foxp3+ regulatory T cells: lessons from mouse models and implications for human disease. Diabetes Metab. Res. Rev. 25:208.
4. Chatenoud, L., Primo, J. and Bach, J. F. 1997. CD3 antibodyinduced dominant self tolerance in overtly diabetic NOD mice. J. Immunol. 158:2947.
5. Klein, L., Khazaie, K. and von Boehmer, H. 2003. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. U. S. A. 100:8886.
6. Jaeckel, E., von Boehmer, H. and Manns, M. P. 2005. Antigenspecific FoxP3-transduced T-cells can control established type 1 diabetes. Diabetes 54:306.
7. von Boehmer, H. 2005. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6:338.
8. Askenasy, N., Kaminitz, A. and Yarkoni, S. 2008. Mechanisms of T regulatory cell function. Autoimmun. Rev. 7:370.
9. Sakaguchi, S., Wing, K., Onishi, Y., Prieto-Martin, P. and Yamaguchi, T. 2009. Regulatory T cells: how do they suppress immune responses? Int. Immunol. 21:1105.
10. Shevach, E. M. 2009. Mechanisms of foxp3+ T regulatory cellmediated suppression. Immunity 30:636.
11. Pandiyan, P., Zheng, L., Ishihara, S., Reed, J. and Lenardo, M. J. 2007. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat. Immunol. 8:1353.
12. Grossman, W. J., Verbsky, J. W., Barchet, W., Colonna, M., Atkinson, J. P. and Ley, T. J. 2004. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21:589.
13. Bryl, E., Daca, A., Józwik, A. and Witkowski, J. M. 2009. Human CD4low CD25high regulatory T cells indiscriminately kill autologous activated T cells. Immunology 128(Suppl 1):e287.
14. Janssens, W., Carlier, V., Wu, B., VanderElst, L., Jacquemin, M. G. and Saint-Remy, J. M. 2003. CD4+CD25+ T cells lyse antigenpresenting B cells by Fas-Fas ligand interaction in an epitopespecific manner. J. Immunol. 171:4604.
15. Weber, S. E., Harbertson, J., Godebu, E. et al. 2006. Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo. J. Immunol. 176:4730.
16. Yolcu, E. S., Ash, S., Kaminitz, A., Sagiv, Y., Askenasy, N. and Yarkoni, S. 2008. Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression. Immunol. Cell Biol. 86:650.
17. Kaminitz, A., Stein, J., Yaniv, I. and Askenasy, N. 2007. The vicious cycle of apoptotic beta-cell death in type 1 diabetes. Immunol. Cell Biol. 85:582.
18. von Herrath, M., Sanda, S. and Herold, K. 2007. Type 1 diabetes as a relapsing-remitting disease? Nat. Rev. Immunol. 7:988.
19. Kaminitz, A., Mizrahi, K., Yaniv, I., Farkas, D. L., Stein, J. and Askenasy, N. 2009. Low levels of allogeneic but not syngeneic hematopoietic chimerism reverse autoimmune insulitis in prediabetic NOD mice. J. Autoimmun. 33:83.
20. Kaminitz, A., Yolcu, E. S., Askenasy, E. M. et al. 2011. Effector and naturally occurring regulatory T cells display no abnormalities in activation induced cell death in NOD mice. PLoS One. 6:e21630.
21. Franke, D. D., Yolcu, E. S., Alard, P., Kosiewicz, M. M. and Shirwan, H. 2007. A novel multimeric form of FasL modulates the ability of diabetogenic T cells to mediate type 1 diabetes in an adoptive transfer model. Mol. Immunol. 44:2884.
22. Kaminitz, A., Yolcu, E. S., Stein, J., Yaniv, I., Shirwan, H. and Askenasy, N. 2011. Killer Treg restore immune homeostasis and suppress autoimmune diabetes in prediabetic NOD mice. J. Autoimmun. 37:39.
23. Kaminitz, A., Mizrahi, K., Yaniv, I., Stein, J. and Askenasy, N. 2010. Immunosuppressive therapy exacerbates autoimmunity in NOD mice and diminishes the protective activity of regulatory T cells. J. Autoimmun. 35:145.
24. Yarkoni, S., Kaminitz, A., Sagiv, Y. and Askenasy, N. 2010. Targeting of IL-2 receptor with a caspase fusion protein disrupts autoimmunity in prediabetic and diabetic NOD mice. Diabetologia 53:356.
25. Yarkoni, S., Prigozhina, T. B., Slavin, S. and Askenasy, N. 2012. IL-2-targeted therapy ameliorates the severity of graft-versus-host disease: ex vivo selective depletion of host-reactive T cells and in vivo therapy. Biol. Blood Marrow Transplant. 18:523.
26. Iskovich, S., Goldenberg-Cohen, N., Stein, J., Yaniv, I., Fabian, I. and Askenasy, N. 2012. Elutriated stem cells derived from the adult bone marrow differentiate into insulin-producing cells in vivo and reverse chemical diabetes. Stem Cells Dev. 21:86.
27. Askenasy, N., Yolcu, E. S., Yaniv, I. and Shirwan, H. 2005. Induction of tolerance using Fas ligand: a double-edged immunomodulator. Blood 105:1396.
28. Tonkin, D. R., He, J., Barbour, G. and Haskins, K. 2008. Regulatory T cells prevent transfer of type 1 diabetes in NOD mice only when their antigen is present in vivo. J. Immunol. 181:4516.
29. Peakman, M. and von Herrath, M. 2010. Antigen-specific immunotherapy for type 1 diabetes: maximizing the potential. Diabetes 59:2087.
30. Yaniv, I., Ash, S., Farkas, D. L., Askenasy, N. and Stein, J. 2009. Consideration of strategies for hematopoietic cell transplantation. J. Autoimmun. 33:255.
31. Askenasy, E. M., Askenasy, N. and Askenasy, J. J. 2010. Does lymphopenia preclude restoration of immune homeostasis? The particular case of type 1 diabetes. Autoimmun. Rev. 9:687.
32. Pearl-Yafe, M., Iskovich, S., Kaminitz, A., Stein, J., Yaniv, I. and Askenasy, N. 2006. Does physiological beta cell turnover initiate autoimmune diabetes in the regional lymph nodes? Autoimmun. Rev. 5:338.
33. Kaminitz A, Askenasy N, Yolcu E. S. 2013. Immunomodulation with regulatory T cells and Fas-ligand ameliorate established inflammatory colitis. Gut, in press.
34. Zelenay, S., Lopes-Carvalho, T., Caramalho, I., Moraes-Fontes, M. F., Rebelo, M. and Demengeot, J. 2005. Foxp3+ CD25-CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc. Natl. Acad. Sci. U. S. A. 102:4091.
35. Komatsu, N., Mariotti-Ferrandiz, M. E., Wang, Y., Malissen, B., Waldmann, H. and Hori, S. 2009. Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc. Natl. Acad. Sci. U. S. A. 106:1903.
36. Stephens, L. A. and Mason, D. 2000. CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25-subpopulations. J. Immunol. 165:3105.
37. Gavin, M. A., Clarke, S. R., Negrou, E., Gallegos, A. and Rudensky, A. 2002. Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo. Nat. Immunol. 3:33.
38. Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G. and Rudensky, A. Y. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22:329.
39. Fontenot, J. D., Rasmussen, J. P., Gavin, M. A. and Rudensky, A. Y. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6:1142.
40. Pedersen, A. E. and Lauritsen, J. P. 2009. CD25 shedding by human natural occurring CD4+CD25+ regulatory T cells does not inhibit the action of IL-2. Scand. J. Immunol. 70:40.
41. Chen, W., Jin, W., Hardegen, N. et al. 2003. Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198:1875.
42. Curotto de Lafaille, M. A., Lino, A. C., Kutchukhidze, N. and Lafaille, J. J. 2004. CD25-T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion. J. Immunol. 173:7259.
43. Liang, S., Alard, P., Zhao, Y., Parnell, S., Clark, S. L. and Kosiewicz, M. M. 2005. Conversion of CD4+ CD25-cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus. J. Exp. Med. 201:127.
44. Tang, Q., Adams, J. Y., Penaranda, C. et al. 2008. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28:687.
45. Yamazaki, S., Iyoda, T., Tarbell, K. et al. 2003. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198:235.
46. Tang, Q., Henriksen, K. J., Bi, M. et al. 2004. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199:1455.
47. Tarbell, K. V., Yamazaki, S., Olson, K., Toy, P. and Steinman, R. M. 2004. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199:1467.
48. Putnam, A. L., Vendrame, F., Dotta, F. and Gottlieb, P. A. 2005. CD4+CD25 high regulatory T cells in human autoimmune diabetes. J. Autoimmun. 24:55.
49. Iskovich, S., Kaminitz, A., Yafe, M. P. et al. 2007. Participation of adult bone marrow-derived stem cells in pancreatic regeneration: neogenesis versus endogenesis. Curr. Stem Cell Res. Ther. 2:272.